Tetanus

Organism/Toxin

C. tetani: anaerobic spore-forming GPB, TERMINAL spore = “drumstick”/“tennis racquet” morphology (see Gas Gangrene topic for shared clostridial biology). Disease = TOXIN-mediated (tetanospasmin), NOT invasion — organism stays localized at wound, toxin does the work. Parallels Botulism/Diphtheria pattern (localized organism, systemic toxin effect).

Mechanism — CONTRAST with Botulism (high-yield)

Tetanospasmin: retrograde AXONAL TRANSPORT up motor neurons → spinal cord/brainstem → blocks INHIBITORY neurotransmitter release (GABA, glycine) → UNOPPOSED motor firing → RIGID/SPASTIC paralysis. Botulinum: blocks EXCITATORY ACh release at NMJ → FLACCID paralysis. Same clostridial-neurotoxin strategy, OPPOSITE clinical pictures — key testable contrast.

Clinical

Trismus (lockjaw) = earliest/classic sign (masseter spasm). Risus sardonicus = fixed facial grimace. Progressive rigidity → opisthotonus (severe spinal hyperextension) = advanced disease. Painful spasms (spontaneous/triggered) superimposed on rigidity — DANGEROUS: respiratory/laryngeal muscle spasm → airway compromise/respiratory failure = principal mortality cause. Autonomic instability (labile BP, tachycardia, arrhythmia) = severe disease feature.

Neonatal Tetanus

Umbilical stump contamination — unhygienic cord-cutting + inadequate maternal toxoid immunization. Presents: can’t suck/feed (trismus) → generalized rigidity/spasms. High mortality untreated. → basis for maternal tetanus toxoid emphasis in high-risk delivery settings.

Diagnosis

CLINICAL ONLY — no reliable lab test. Wound culture often negative (low bacterial burden, toxin not organism drives disease). Serum antitoxin doesn’t distinguish active disease vs prior immunization. Clinical suspicion + immunization history drive treatment, don’t wait for labs.

Treatment

Debridement (remove anaerobic toxin-producing focus) + Human Tetanus Immunoglobulin (TIG) — neutralizes UNBOUND circulating toxin only (can’t reverse toxin already in neurons — early Tx matters) + Metronidazole (antibiotic of choice) + supportive (muscle relaxants/sedation, ventilation if severe).

KEY POINT: NO durable natural immunity after clinical tetanus (toxin dose too small for protective Ab response) — unlike most infections. ACTIVE IMMUNIZATION REQUIRED even post-recovery — testable contrast with usual “infection = future protection” rule.

Prevention

Routine toxoid immunization (DPT/Tdap) + wound management protocol (risk-assess wound, give booster/TIG per immunization history + wound type).

The Organism and Its Toxin

Clostridium tetani is an anaerobic, spore-forming, gram-positive bacillus (see Gas Gangrene and Clostridial Infections for the general clostridial biology this organism shares with its gas-gangrene-causing relatives), genuinely distinctive for its terminal spore giving the classic “drumstick” or “tennis racquet” microscopic appearance. Disease is caused entirely by a potent exotoxin, tetanospasmin, rather than by tissue invasion — the organism itself typically remains localized at the site of a wound, with the toxin doing essentially all the clinically relevant work, genuinely paralleling the same localized-organism/systemically-acting-toxin pattern already established under Botulism (caused by the related organism Clostridium botulinum) and Diphtheria, though the specific toxin mechanism and resulting clinical picture differ substantially between all three.

Mechanism — A Direct, Instructive Contrast with Botulism

Tetanospasmin travels from the wound site by retrograde axonal transport up peripheral motor neurons to reach the spinal cord and brainstem, where it blocks the release of inhibitory neurotransmitters (GABA and glycine) from inhibitory interneurons — the practical consequence is unopposed, uncontrolled motor neuron firing, producing sustained muscle spasm and rigidity. This is genuinely worth holding in direct, deliberate contrast with botulinum toxin’s mechanism (blocking excitatory acetylcholine release at the neuromuscular junction, producing flaccid paralysis) — the same general “clostridial neurotoxin disrupting neurotransmission” strategy, applied by the two organisms to produce clinically opposite pictures (tetanus: rigid/spastic; botulism: flaccid), a genuinely high-yield, specifically testable point of physiological contrast between two topics covered in the same curriculum.

Clinical Manifestations

Trismus (lockjaw) — spasm of the masseter muscles limiting jaw opening — is classically the earliest and most recognizable presenting sign, followed by risus sardonicus (a fixed, sardonic facial grimace from sustained facial muscle spasm) and progressive generalized muscle rigidity. Opisthotonus (severe spinal hyperextension from sustained back muscle spasm) reflects more advanced, severe disease. Superimposed on this background rigidity, painful, spontaneous or stimulus-triggered generalized muscle spasms occur, genuinely dangerous because they can compromise respiratory function (spasm of respiratory and laryngeal muscles causing airway compromise or respiratory failure) — this respiratory risk is the principal cause of tetanus mortality and drives much of the intensive-care-level management severe cases require. Autonomic instability (labile blood pressure, tachycardia, arrhythmias) is a genuine feature of severe disease, reflecting toxin effects beyond the purely motor system.

Neonatal Tetanus

A genuinely important, specific clinical entity worth distinguishing: neonatal tetanus occurs when C. tetani spores contaminate the umbilical stump, classically in settings with unhygienic cord-cutting practices and inadequate maternal tetanus immunization — presenting with the newborn’s characteristic inability to suck/feed (from trismus) progressing to generalized rigidity and spasms, and carrying a genuinely high mortality without prompt recognition and treatment. This entity is specifically why maternal tetanus toxoid immunization during pregnancy is emphasized as a public health priority in regions where unhygienic delivery/cord care practices persist.

Diagnosis

Tetanus diagnosis is made clinically, based on the characteristic history (wound, often relatively minor or even unnoticed) and examination findings — there is genuinely no reliable specific laboratory test, since organism culture from the wound is frequently negative (the localized bacterial burden is often too low, again reflecting that toxin, not organism burden, drives disease) and serum antitoxin antibody levels do not reliably distinguish active disease from prior immunization. This absence of a confirmatory lab test is a genuinely important, specifically testable point — it means clinical suspicion and history (particularly immunization status) must drive both diagnosis and treatment decisions without waiting for laboratory confirmation.

Treatment and Prevention

Management combines wound debridement (removing the anaerobic, toxin-producing focus), human tetanus immunoglobulin (TIG) to neutralize circulating, unbound toxin (unable to reverse toxin already bound within neurons, which is why early administration matters), metronidazole as the antibiotic of choice (targeting the anaerobic organism itself), and supportive care — muscle relaxants/sedation for spasm control and, in severe cases, mechanical ventilation for respiratory compromise. Genuinely important: tetanus does not confer durable natural immunity (unlike many other toxin-mediated or infectious diseases), because the toxin dose causing clinical disease is typically too small to generate a protective antibody response — meaning active immunization (tetanus toxoid) is required even after recovering from clinical tetanus, a real, specifically testable point of contrast with the general principle that natural infection usually confers at least some future protection. Primary prevention rests on routine tetanus toxoid immunization (as part of combination vaccines, e.g. DPT/Tdap) with wound management protocols (assessing wound tetanus-risk and administering toxoid booster and/or TIG based on immunization history and wound characteristics) forming the standard post-exposure preventive framework.